Longevity Aeovian lands $55m to advance pipeline focused on mTOR biologyBy adminDecember 16, 20250 Initial focus on epilepsy could drive progress in aging and healthspan therapeutics targeting the mTOR pathway. US biotech Aeovian Pharmaceuticals…
Longevity mTOR science has skin in the gameBy adminOctober 31, 20250 Rapalogix Health launches Re-Q, a skincare line featuring an mTORC1-selective inhibitor that connects geroscience with dermatology. For more than a…
